Ibarra Real

Trump Administration Shuts Down Critical HIV Vaccine Program—What It Means for Future Research

The Trump administration’s shutdown of a $258M HIV vaccine program threatens to delay progress by a decade. With trials disrupted and jobs lost, researchers warn this decision could undo years of progress toward a universal vaccine. Institutions like Duke and Scripps are left in limbo, and global efforts in South Africa and Brazil are affected. Experts urge Congress to reinstate funding and protect HIV research infrastructure.